About IntegraGen

Company Description

IntegraGen is an OncoDNA Group company specializing in the genomics of cancer and genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in genomic services which has been operating sequencing platforms for research institutes of excellence.

IntegraGen's mission is to translate molecular research into clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in providing cutting-edge genomic services to academic researchers and life sciences companies based on the company's technological expertise and scientific know-how.

Year founded

2000

Served area

Worldwide

Headcount

50

Headquarters

Genopole Campus 1 - Bâtiment 8 5 Rue de Henri Desbruères, 91000 Évry – France

Shareholder information

Shares outstanding

6,727,332

IPO

June 18, 2010

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.